Autoimmune Hemolytic Anemia Clinical Trials

50 clinical trials for Autoimmune Hemolytic Anemia across international registries, including 16 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• HY001N for Patients With Autoimmune Hemolytic Anemia After Failure ≥3 Lines of Therapy. — RECRUITING · PHASE1
• A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia — RECRUITING · PHASE1
• Orelabrutinib in the Treatment of Relapsed/Refractory AIHA — RECRUITING · PHASE2
• Evaluation of Safety, Pharmacokinetics and Pharmacodynamics of Arnovie101, an mRNA-LNP-Based In Vivo CAR-T Therapy, for the Treatment of B Cell-Mediated Autoimmune Diseases (SLE and AIHA) — RECRUITING · PHASE1
• Brain Cognitive Network Abnormalities in Anemia Patients Using fNIRS — RECRUITING
• UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases — RECRUITING · PHASE1
• French Registry of Adult Patients With Immune Thrombocytopenia and Autoimmune Hemolytic Anemia — RECRUITING
• Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study — RECRUITING · PHASE2
• A Study of CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia — RECRUITING · PHASE1
• Safety Study of CC312 in Autoimmune Disease Patients — RECRUITING · PHASE1
• Brain Function and Psychological Changes Related to Cell Therapy for Autoimmune Hemolytic Anemia — RECRUITING
• Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia — RECRUITING
• CAR T-cell Therapy Targeting CD19 and BCMA in Patients with AIHA Who Have Failed ≥3 Lines of Therapy. — RECRUITING · PHASE1
• Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune Neutropenia — RECRUITING
• Ibrutinib for the Treatment of AIHA in Patients With CLL/SLL or CLL-like MBL — RECRUITING · PHASE2
• OBS'CEREVANCE: French Cohort of Pediatric Autoimmune Cytopenia — RECRUITING
• Study of Zola-cel (BMS-986353), in Participants With Autoimmune Cytopenia (Breakfree-AiCE) — NOT_YET_RECRUITING · PHASE2
• META 10-19 in Patients With Relapsed/Refractory Autoimmune Hemolytic Anemia — NOT_YET_RECRUITING · PHASE1
• CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refractory Immune-related Cytopenia — NOT_YET_RECRUITING · PHASE1
• Evaluating the Interest of Interleukine-2 for Patients With Active Warm Hemolytic Anemia Resistant to Conventional Treatment — TERMINATED · PHASE1
• IASO206 in Patients With Relapsed/Refractory Autoimmune Hemolytic Anemia — NOT_YET_RECRUITING · PHASE1
• Acalabrutinib for the Treatment of Relapsed or Refractory Autoimmune Hemolytic Anemia in Patients With Chronic Lymphocytic Leukemia — ACTIVE_NOT_RECRUITING · PHASE2
• A Multicenter, Prospective, Randomized Controlled Study Comparing Glucocorticoid Combined With Sirolimus With Monotherapy of Glucocorticoid in the Treatment of Newly Diagnosed Mild Autoimmune Hemolytic Anemia — NOT_YET_RECRUITING · NA
• Research on YTS109 Cell in Patients With Recurrent/Refractory Autoimmune Hemolytic Anemia — NOT_YET_RECRUITING · PHASE1
• A Study of YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia — COMPLETED · PHASE1
• PI3K Delta Inhibitor in Relapsed / Refractory Autoimmune Hemolytic Anemia Patients After Receiving Two or More Lines of Therapy — TERMINATED · PHASE1
• Immunopathology of Autoimmune Hemolytic Anemia — COMPLETED
• A Study of YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia — NOT_YET_RECRUITING · PHASE1
• API-AHAI - Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study — TERMINATED · PHASE2
• Severe Immune Cytopenia Registry Www.Sic-reg.Org — COMPLETED
• A Single-arm Phase 2 Prospective Clinical Study of Enatumab in the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia — NOT_YET_RECRUITING · PHASE2
• A Single-arm Phase 2 Prospective Clinical Study of Linprixel in the Treatment of Relapsed/Refractory Autoimmune Hemolytic Anemia — NOT_YET_RECRUITING
• A Study of INCB050465 in Participants With Autoimmune Hemolytic Anemia — COMPLETED · PHASE2
• UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases — NOT_YET_RECRUITING · PHASE1
• CNCT19 for Patients With Autoimmune Hemolytic Anemia After Failure ≥3 Lines of Therapy. — ACTIVE_NOT_RECRUITING · PHASE1
• A Study of YTS109 Cell Injection in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia — NOT_YET_RECRUITING · PHASE1
• Role of T Follicular Helper Cells in Autoimmune Hemolytic Anemia (TFH in AIHA) — COMPLETED
• Single-dose Anti-CD20 Antibody With Bortezomib for Relapsed Refractory Autoimmune Hemolytic Anemia — COMPLETED · PHASE2
• CAR-T for Autoimmune Hemolytic Anemia Patients Who Have Failed Three or More Lines of Therapy — OTHER · PHASE1
• Presence of Circulating Cluster of Differentiation 4 Positive 28 Null T Helper Lymphocytes(CD4+CD28-) in Patients With Autoimmune Hemolytic Anemia. — OTHER
• A Clinical Study of CD19/BCMA CAR-T Cells in the Treatment of Refractory POEMS Syndrome, Amyloidosis, Autoimmune Hemolytic Anemia, and Vasculitis — OTHER · PHASE1
• Reappraisal of the Therapies of Refractory Autoimmune Hemolytic Anemia in Systemic Lupus Erythematosus — OTHER · PHASE3
• The Significance of Release of T-follicular Helper and T-follicular Regulatory Cells in Autoimmune Haemolytic Anemia Before and After Tratment — NOT_YET_RECRUITING
• Clinical Characteristics and Treatment Outcomes of Patients With Autoimmune Hemolytic Anemia — COMPLETED
• A Phase 2 Study to Evaluate the Safety and Efficacy of KZR-616 in Patients With AIHA and ITP — WITHDRAWN · PHASE2
• Tacrolimus Treatment for Refractory Autoimmune Cytopenia — OTHER · PHASE4
• Balance Benefit / Risk of Immunomodulatory Treatments at the Child and Adolescent for Autoimmune Cytopenia. — COMPLETED
• Data Registry of Auto Immune Hemolytic Anemia — OTHER
• Treatment of Autoimmune Thrombocytopenia (AITP) — COMPLETED · PHASE1
• Bendamustine and Rituximab Combination Therapy for Cold Agglutinin Disease — COMPLETED · PHASE2

Refine this search